Home LiteratureArticle Details
PMID: 11359930 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation.

Molecular biology of the cell ·Vol. 12 ·No. 5 ·2001-05-00 ·Pages 1393-407

Waelter S, Boeddrich A, Lurz R, Scherzinger E, Lueder G, Lehrach H, Wanker EE

Abstract

The huntingtin exon 1 proteins with a polyglutamine repeat in the pathological range (51 or 83 glutamines), but not with a polyglutamine tract in the normal range (20 glutamines), form aggresome-like perinuclear inclusions in human 293 Tet-Off cells. These structures contain aggregated, ubiquitinated huntingtin exon 1 protein with a characteristic fibrillar morphology. Inclusion bodies with truncated huntingtin protein are formed at centrosomes and are surrounded by vimentin filaments. Inhibition of proteasome activity resulted in a twofold increase in the amount of ubiquitinated, SDS-resistant aggregates, indicating that inclusion bodies accumulate when the capacity of the ubiquitin-proteasome system to degrade aggregation-prone huntingtin protein is exhausted. Immunofluorescence and electron microscopy with immunogold labeling revealed that the 20S, 19S, and 11S subunits of the 26S proteasome, the molecular chaperones BiP/GRP78, Hsp70, and Hsp40, as well as the RNA-binding protein TIA-1, the potential chaperone 14-3-3, and alpha-synuclein colocalize with the perinuclear inclusions. In 293 Tet-Off cells, inclusion body formation also resulted in cell toxicity and dramatic ultrastructural changes such as indentations and disruption of the nuclear envelope. Concentration of mitochondria around the inclusions and cytoplasmic vacuolation were also observed. Together these findings support the hypothesis that the ATP-dependent ubiquitin-proteasome system is a potential target for therapeutic interventions in glutamine repeat disorders.

MeSH Terms
14-3-3 Proteins Acetylcysteine/analogs & derivatives,pharmacology Carrier Proteins/metabolism Cell Line Cysteine Endopeptidases/metabolism Cysteine Proteinase Inhibitors/pharmacology Endoplasmic Reticulum Chaperone BiP Exons Heat-Shock Proteins Humans Huntingtin Protein Huntington Disease/metabolism Immunoblotting Inclusion Bodies/metabolism,ultrastructure Membrane Proteins/metabolism Microscopy, Fluorescence Models, Biological Molecular Chaperones/metabolism Multienzyme Complexes/antagonists & inhibitors,metabolism Mutation Nerve Tissue Proteins/genetics,metabolism Nuclear Proteins/genetics,metabolism Peptide Fragments/genetics,metabolism Poly(A)-Binding Proteins Proteasome Endopeptidase Complex Proteins RNA-Binding Proteins/metabolism Recombinant Fusion Proteins/genetics,metabolism Synucleins T-Cell Intracellular Antigen-1 Transgenes Tyrosine 3-Monooxygenase/metabolism Vimentin/metabolism alpha-Synuclein
Chemicals
14-3-3 Proteins Carrier Proteins Cysteine Proteinase Inhibitors Endoplasmic Reticulum Chaperone BiP HSPA5 protein, human HTT protein, human Heat-Shock Proteins Huntingtin Protein Membrane Proteins Molecular Chaperones Multienzyme Complexes Nerve Tissue Proteins Nuclear Proteins Peptide Fragments Poly(A)-Binding Proteins Proteins RNA-Binding Proteins Recombinant Fusion Proteins SNCA protein, human Synucleins T-Cell Intracellular Antigen-1 TIA1 protein, human Vimentin alpha-Synuclein lactacystin Tyrosine 3-Monooxygenase Cysteine Endopeptidases Proteasome Endopeptidase Complex Acetylcysteine
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Waelter S
Max-Planck-Institut für Molekulare Genetik, D-14195 Berlin (Dahlem), Germany. [email protected]
Boeddrich A
Lurz R
Scherzinger E
Lueder G
Lehrach H
Wanker E E
References (55)
55 references, click to expand
  1. The 26S proteasome: a molecular machine designed for controlled proteolysis.
    Annu Rev Biochem. 1999;68:1015-68 PMID: 10872471
  2. TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha.
    EMBO J. 2000 Aug 1;19(15):4154-63 PMID: 10921895
  3. alpha-Synuclein shares physical and functional homology with 14-3-3 proteins.
    J Neurosci. 1999 Jul 15;19(14):5782-91 PMID: 10407019
  4. Decreased expression of striatal signaling genes in a mouse model of Huntington's disease.
    Hum Mol Genet. 2000 May 22;9(9):1259-71 PMID: 10814708
  5. Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells.
    Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11404-9 PMID: 10500189
  6. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1.
    Nat Genet. 1998 Jun;19(2):148-54 PMID: 9620770
  7. Protein fate in neurodegenerative proteinopathies: polyglutamine diseases join the (mis)fold.
    Am J Hum Genet. 1999 Feb;64(2):339-45 PMID: 9973270
  8. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.
    Science. 1997 Sep 26;277(5334):1990-3 PMID: 9302293
  9. Cell type-dependent variations in the subcellular distribution of alpha-mannosidase I and II.
    J Cell Biol. 1993 Jul;122(1):39-51 PMID: 8314846
  10. Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates.
    Nat Genet. 1998 Feb;18(2):150-4 PMID: 9462744
  11. Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy.
    Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6739-44 PMID: 10829068
  12. RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2 alpha to the assembly of mammalian stress granules.
    J Cell Biol. 1999 Dec 27;147(7):1431-42 PMID: 10613902
  13. Mitochondria as the central control point of apoptosis.
    Trends Cell Biol. 2000 Sep;10(9):369-77 PMID: 10932094
  14. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
    Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5547-51 PMID: 1319065
  15. Chaperone-like activity of synucleins.
    FEBS Lett. 2000 May 26;474(1):116-9 PMID: 10828462
  16. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease.
    Nature. 1995 Jun 29;375(6534):754-60 PMID: 7596406
  17. Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone.
    Hum Mol Genet. 1999 May;8(5):731-41 PMID: 10196362
  18. Aggresomes: a cellular response to misfolded proteins.
    J Cell Biol. 1998 Dec 28;143(7):1883-98 PMID: 9864362
  19. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70.
    Nat Genet. 1999 Dec;23(4):425-8 PMID: 10581028
  20. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo.
    Cell. 1997 Aug 8;90(3):549-58 PMID: 9267034
  21. Membrane filter assay for detection of amyloid-like polyglutamine-containing protein aggregates.
    Methods Enzymol. 1999;309:375-86 PMID: 10507036
  22. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease.
    Cell. 2000 Mar 31;101(1):57-66 PMID: 10778856
  23. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease.
    Nature. 1999 May 20;399(6733):263-7 PMID: 10353249
  24. The 14-3-3 proteins.
    Curr Biol. 2000 Jun 1;10(11):R400 PMID: 10837257
  25. Alpha-synuclein immunoreactivity of huntingtin polyglutamine aggregates in striatum and cortex of Huntington's disease patients and transgenic mouse models.
    Neurosci Lett. 2000 Jul 28;289(1):29-32 PMID: 10899401
  26. 14-3-3 and its possible role in co-ordinating multiple signalling pathways.
    Trends Cell Biol. 1996 Sep;6(9):341-7 PMID: 15157431
  27. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.
    Cell. 1998 Oct 2;95(1):55-66 PMID: 9778247
  28. Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases.
    Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5355-8 PMID: 8202492
  29. Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state.
    EMBO J. 1992 Jun;11(6):2131-8 PMID: 1376245
  30. Amyloid plaque core protein in Alzheimer disease and Down syndrome.
    Proc Natl Acad Sci U S A. 1985 Jun;82(12):4245-9 PMID: 3159021
  31. Energetics in the pathogenesis of neurodegenerative diseases.
    Trends Neurosci. 2000 Jul;23(7):298-304 PMID: 10856939
  32. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.
    Science. 1997 Jun 27;276(5321):2045-7 PMID: 9197268
  33. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.
    Nat Med. 1998 Nov;4(11):1318-20 PMID: 9809558
  34. Molecular chaperones in cellular protein folding.
    Nature. 1996 Jun 13;381(6583):571-9 PMID: 8637592
  35. 14-3-3 proteins block apoptosis and differentially regulate MAPK cascades.
    EMBO J. 2000 Feb 1;19(3):349-58 PMID: 10654934
  36. Dynamic association of proteasomal machinery with the centrosome.
    J Cell Biol. 1999 May 3;145(3):481-90 PMID: 10225950
  37. Neuropathological classification of Huntington's disease.
    J Neuropathol Exp Neurol. 1985 Nov;44(6):559-77 PMID: 2932539
  38. Calyculin A-induced vimentin phosphorylation sequesters 14-3-3 and displaces other 14-3-3 partners in vivo.
    J Biol Chem. 2000 Sep 22;275(38):29772-8 PMID: 10887173
  39. Neurofibrillary tangles of Alzheimer's disease brains contain 14-3-3 proteins.
    Neurosci Lett. 1996 May 3;209(1):57-60 PMID: 8734909
  40. A cellular model that recapitulates major pathogenic steps of Huntington's disease.
    Hum Mol Genet. 1998 Sep;7(9):1355-61 PMID: 9700187
  41. Mutant analysis links the translocon and BiP to retrograde protein transport for ER degradation.
    Nature. 1997 Aug 28;388(6645):891-5 PMID: 9278052
  42. ER quality control: the cytoplasmic connection.
    Cell. 1997 Feb 21;88(4):427-30 PMID: 9038332
  43. Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture.
    Hum Mol Genet. 1998 May;7(5):783-90 PMID: 9536081
  44. Degradation of CFTR by the ubiquitin-proteasome pathway.
    Cell. 1995 Oct 6;83(1):121-7 PMID: 7553863
  45. Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats.
    Am J Hum Genet. 1996 Jul;59(1):16-22 PMID: 8659522
  46. Pericentrin and gamma-tubulin form a protein complex and are organized into a novel lattice at the centrosome.
    J Cell Biol. 1998 Apr 6;141(1):163-74 PMID: 9531556
  47. Establishment of stable cell lines expressing potentially toxic proteins by tetracycline-regulated and epitope-tagging methods.
    Biotechniques. 1996 Oct;21(4):718-22, 724-5 PMID: 8891226
  48. Association of 14-3-3 proteins with centrosomes.
    Blood Cells Mol Dis. 1996;22(3):225-37 PMID: 9075573
  49. Identification of an HD patient with a (CAG)180 repeat expansion and the propagation of highly expanded CAG repeats in lambda phage.
    Hum Genet. 1997 May;99(5):692-5 PMID: 9150744
  50. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.
    Cell. 1997 Aug 8;90(3):537-48 PMID: 9267033
  51. Ubiquitin and the control of protein fate in the secretory and endocytic pathways.
    Annu Rev Cell Dev Biol. 1998;14:19-57 PMID: 9891777
  52. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro.
    Hum Mol Genet. 1999 Apr;8(4):673-82 PMID: 10072437
  53. Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils.
    Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):7841-6 PMID: 10859365
  54. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice.
    Cell. 1998 Oct 2;95(1):41-53 PMID: 9778246
  55. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology.
    Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4604-9 PMID: 10200309
Article Info
Journal
Molecular biology of the cell
Abbr.
Mol Biol Cell
ISSN
1059-1524
Published
2001-05-00
Pages
1393-407
Language
English
Region
United States
NLM ID
9201390
PMCID
PMC34592
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]